Ankyrin B (ANK2) is a large cytoplasmic protein belonging to the ankyrin family of membrane adaptor proteins. The ANK2 gene encodes a 220 kDa protein that plays a critical role in organizing the subcellular architecture of neurons and cardiac myocytes through direct interactions with ion channels, transporters, and the cytoskeleton. Ankyrin B is predominantly localized at the axon initial segment (AIS), nodes of Ranvier, and the endoplasmic reticulum-plasma membrane interface in neurons, where it serves as a crucial scaffolding molecule. The protein contains a characteristic N-terminal ankyrin repeat domain consisting of 24 tandem repeats that facilitate protein-protein interactions, followed by a spectrin-binding domain and a C-terminal regulatory domain.
Ankyrin B (ANK2) is a large cytoplasmic protein belonging to the ankyrin family of membrane adaptor proteins. The ANK2 gene encodes a 220 kDa protein that plays a critical role in organizing the subcellular architecture of neurons and cardiac myocytes through direct interactions with ion channels, transporters, and the cytoskeleton. Ankyrin B is predominantly localized at the axon initial segment (AIS), nodes of Ranvier, and the endoplasmic reticulum-plasma membrane interface in neurons, where it serves as a crucial scaffolding molecule. The protein contains a characteristic N-terminal ankyrin repeat domain consisting of 24 tandem repeats that facilitate protein-protein interactions, followed by a spectrin-binding domain and a C-terminal regulatory domain.
Ankyrin B functions primarily as a membrane adaptor protein that connects integral membrane proteins to the underlying spectrin-based cytoskeleton. At the molecular level, it mediates the binding of Na+/K+-ATPase, the Na+/Ca2+ exchanger (NCX), and the inositol 1,4,5-trisphosphate receptor (IP3R) to the spectrin-actin network. In neurons, Ankyrin B is essential for maintaining the structural integrity of the AIS, the specialized neuronal compartment where action potentials are initiated. The protein also participates in organizing the ER-plasma membrane junction through its interaction with the IP3R, facilitating calcium signaling and store-operated calcium entry. Additionally, Ankyrin B helps stabilize voltage-gated ion channels, particularly sodium and potassium channels, which are critical for proper neuronal excitability and signal propagation.
Emerging evidence implicates Ankyrin B dysfunction in several neurodegenerative conditions. Loss or mutation of ANK2 leads to disorganization of the AIS and nodal regions, compromising neuronal excitability and potentially contributing to pathological network hyperexcitability observed in Alzheimer's disease and other dementias. Ankyrin B also interacts with amyloid precursor protein (APP), and alterations in this interaction may influence amyloid-beta metabolism and clearance. In Parkinson's disease models, diminished Ankyrin B levels correlate with impaired cellular calcium homeostasis and increased vulnerability to alpha-synuclein toxicity. The protein's role in maintaining ER-plasma membrane coupling suggests involvement in calcium dysregulation, a hallmark feature of multiple neurodegeneration pathways. Ankyrin B dysfunction may precipitate neuronal death through cumulative effects on ion channel stability, cytoskeletal integrity, and calcium signaling dysregulation.
Ankyrin B loss or mutations disrupt the stable anchoring of membrane proteins to the cytoskeleton, leading to internalization and degradation of sodium pumps and calcium exchangers. This results in impaired ion homeostasis, particularly Na+/K+ and Ca2+ dysregulation, which triggers mitochondrial calcium overload and energy depletion. The protein's interaction with spectrin and actin is mediated through its C-terminal spectrin-binding domain; disruption of this interface compromises cytoskeletal stability and neuronal morphology. Ankyrin B also regulates trafficking and surface localization of NMDA and AMPA receptors through its associations with postsynaptic density proteins, affecting synaptic transmission. Additionally, the protein participates in autophagy regulation through interactions with microtubule-associated proteins, influencing clearance of protein aggregates characteristic of neurodegenerative diseases.
ANK2 mutations have been identified in rare autosomal dominant cardiac arrhythmia syndromes (Ankyrin B-associated Tachycardia), demonstrating the protein's critical role in excitable tissues. Recent research has focused on whether ANK2 variants or expression changes contribute to sporadic Alzheimer's disease, particularly given the protein's involvement in APP metabolism. Ankyrin B has been identified as a potential modifier gene in ALS susceptibility, and its role in maintaining motor neuron structural integrity is an active area of investigation. Therapeutic strategies targeting Ankyrin B restoration or stabilization represent a novel approach to preventing neurodegeneration-associated excitotoxicity and ion dysregulation.
AlphaFold DB provides a predicted structure for ANK2 / UniProt Q01484-7 (model version 6): https://alphafold.ebi.ac.uk/entry/Q01484.
AlphaFold reports a mean pLDDT confidence score of 61.78, indicating moderate confidence, so flexible or poorly constrained regions should be interpreted cautiously.
InterPro domain annotations were unavailable (Could not resolve gene symbol to UniProt accession).
PDB coordinates: https://alphafold.ebi.ac.uk/files/AF-Q01484-7-F1-model_v6.pdb mmCIF coordinates: https://alphafold.ebi.ac.uk/files/AF-Q01484-7-F1-model_v6.cif.
Use the prediction as structural context for target assessment; local low-pLDDT segments may reflect disorder, flexible linkers, or unresolved domain orientation rather than a stable fold.